Outcome of the 86th Annual General Meeting

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Business Responsibility and Sustainability Report for the Financial Year 2024-25

Notice of the 86th Annual General Meeting (AGM) of the Company for FY 2024-25

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Intimation to the holders of physical securities for furnishing of KYC details

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30- Newspaper Advertisement- Public Notice of 86th Annual General Meeting and Record Date

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Communication to Shareholders - Intimation on Tax Deduction on Dividend

Intimation of Schedule of Analysts/Institutional Investors Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of date of 86th Annual General Meeting and Record Date for payment of Dividend

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2025

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 55 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2025

Newspaper Advertisement - Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2025

Outcome of the Board Meeting dated May 7, 2025: Approval of Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended

Outcome of the Board Meeting dated May 7, 2025: Recommendation of Dividend for Financial Year 2024-25

Re-appointment of Independent Director of the Company

Appointment of Secretarial Auditors of the Company

Press Release - Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2025

Analysts/ Investors presentation dated May 7, 2025 for the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2025

Reminder letter to shareholders and advertisement for transfer of shares to Investor Education and Protection fund

Shareholding Pattern as on March 31, 2025

Intimation of the Board Meeting of the Company to be held on May 7, 2025

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation regarding Centralized Database for corporate bonds/ debentures

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of change in contact details of MUFG Intime India Private Limited, Registrar and Transfer Agent of the Company

Specifications related to ISINs for debt securities for the half-year ended March 31, 2025

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Integrated Filing (Governance) for the quarter ended March 31, 2025

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2024

Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2024

Shareholding Pattern as on December 31, 2024

Outcome of the Board Meeting dated February 3, 2025- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024

Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024

Analysts/Investors presentation dated February 3, 2025 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024

Integrated Filing (Financial) for the third quarter and nine months ended December 31, 2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2024

Intimation of the Board Meeting of the Company to be held on February 3, 2025

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation regarding change in name of Company’s Registrar and Transfer Agent (RTA)

Shareholding Pattern as on September 30, 2024

Shareholding pattern as on June 30, 2024

Integrated Filing (Governance) for the quarter ended December 31, 2024

Corporate Governance Report as on September 30, 2024

Corporate Governance Report as on June 30, 2024

Disclosure of Related Party Transactions for the half year ended March 31, 2025 pursuant to SEBI Regulations.

Disclosure of Related Party Transactions for the half year ended September 30, 2024 pursuant to SEBI Regulations

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2024

Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2024

Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Outcome of the Board Meeting dated October 17, 2024- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024

Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024

Analysts/Investors presentation dated October 17, 2024 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024

Statement of utilisation of issue proceeds of NCDs

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2024

Specifications related to ISINs for debt securities for the half year ended September 30, 2024

Intimation of the Board Meeting of the Company to be held on October 17, 2024

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 55 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Completion of tenure of an Independent Director

Intimation of under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Outcome of the Meeting of the Internal Committee - Allotment of Non-Convertible Debentures (NCDs) on Private Placement basis

Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2024

Outcome of the Meeting of Internal Committee – Issue of Non-Convertible Debentures aggregating to 1,700 crore rupees

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended June 30, 2024

Outcome of the Board Meeting dated August 5, 2024- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024

Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024

Analysts/Investors presentation dated August 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2024

Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2024

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Outcome of the 85th Annual General Meeting

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Disclosure under Regulations 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Notice of the 85th Annual General Meeting (‘AGM’) of the Company for FY 2023- 24

Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015 (‘Listing Regulations’)

Business Responsibility and Sustainability Report for the Financial Year 2023-24

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30- Newspaper Advertisement- Public Notice of 85th Annual General Meeting and Record Date

Intimation of date of 85th Annual General Meeting and Record Date for payment of Dividend

Intimation to the holders of physical securities to furnish PAN, KYC details and Nomination as per SEBI Circular dated May 17, 2023

Reminder letter to shareholders and Advertisement for transfer of Shares to Investor Education and Protection Fund (IEPF)

Communication to Shareholders - Intimation on Tax Deduction on Dividend

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Change in the Senior Management Personnel of the Company

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Re-appointment of Directors of the Company

Outcome of the Board Meeting dated April 29, 2024: Approval of Audited Consolidated and Standalone Financial Results of the Company for the fourth quarter and year ended March 31, 2024

Press Release - Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2024

Analysts/ Investors presentation dated April 29, 2024 for the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter and year ended March 31, 2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Update on the Board Meeting to be held on April 29, 2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2024

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

FITCH Ratings affirms Tata Chemicals Limited’s credit rating at BB+ & revises Outlook to Stable

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023

Outcome of the Board Meeting dated February 5, 2024: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2023

Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023

Analyst/Investors Presentation dated February 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation for the Board Meeting of the Company to be held on February 5, 2024

Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 5, 2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Shareholding Pattern as on March 31, 2024

Shareholding Pattern as on December 31, 2023

Shareholding pattern as on September 30, 2023

Shareholding pattern as on June 30, 2023

Corporate Governance Report as on March 31, 2024

Corporate Governance Report as on December 31, 2023

Corporate Governance Report as on September 30, 2023

Corporate Governance Report as on June 30, 2023

Disclosure of Related Party Transactions for the half year ended March 31, 2024 pursuant to SEBI Regulations

Disclosure of Related Party Transactions for the half year ended September 30, 2023 pursuant to SEBI Regulations

Merger of Registrar & Transfer Agent i.e. TSR Consultants Private Limited with Link Intime India Private Limited

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023

Newspaper Advertisement - Unaudited Consolidated and Standalone Financial Results for the second quarter and half yer ended September 30, 2023

Outcome of the Board Meeting dated November 10, 2023: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2023

Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2023

Analyst/Investors Presentation dated November 10, 2023 for Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30 2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023

Intimation under Regulation 30 of SEBI Listing Regulations – update on pending litigations

Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 10, 2023

Intimation for the Board Meeting of the Company to be held on November 10, 2023

Reaffirmation of Credit Rating by CARE Ratings

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023

Outcome of the Board Meeting dated August 7, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2023

Press Release on Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023

Analyst/Investors Presentation dated August 7, 2023 for Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023

Intimation of Re-scheduled Analyst / Institutional Investor Meeting

Intimation for the Board Meeting of the Company to be held on August 7, 2023

Increase of shareholding in Rallis India Limited

Affirmation of Credit Rating by Moody’s

Outcome of the 84th Annual General Meeting

Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement-Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Business Responsibility and Sustainability Report for the Financial Year 2022-23

Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015

Notice of the 84th Annual General Meeting (‘AGM’) of the Company for FY 2022- 23

Re-affirmation of Credit Rating by CRISIL

Intimation regarding simplification of the holding structure of the US operations of Tata Chemicals Limited

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 84th Annual General Meeting and Book Closure'

Submission of Annual Secretarial Compliance Report for the Financial Year 2022-23

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Communication to Shareholders - Intimation on Tax Deduction on Dividend

Intimation to the holders of physical securities to furnish PAN, shareholders KYC details and Nomination as per SEBI Circular dated March 16, 2023

Re-appointment of Director of the Company

Annual General Meeting of the Company and Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Audited Standalone and Consolidated Financial Statements for the fourth quarter and year ended March 31, 2023

Audio Recording of the Analysts/Investors Call pertaining to the Financial Results for the fourth quarter and year ended March 31, 2023

Analyst/Investors Presentation dated May 3, 2023 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023

Press Release on Financial Results for the fourth quarter and year ended March 31, 2023

Outcome of the Board Meeting dated May 3, 2023: Recommendation of Dividend for FY 2022-23

Outcome of the Board Meeting dated May 3, 2023: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023

Stock Exchange Intimation for the Board Meeting of the Company to be held on May 3, 2023

Voting Results of Postal Ballot through remote e-Voting

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange intimation - FITCH Ratings revises Tata Chemicals’ Outlook to Positive

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement – Notice of Postal Ballot and E-Voting Information

Notice of Postal Ballot for re-appointment of Directors

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022

Corrigendum to our letter dated February 1, 2023 intimating the re-appointment of Directors

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022

Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2022

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Outcome of the Board Meeting dated February 1, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022

Press Release on Financial Results for the third quarter and nine months ended December 31, 2022

Analyst/Investors Presentation dated February 1, 2023 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022

Re-appointment of Ms. Padmini Khare Kaicker as Independent Director and Mr. Zarir Langrana as Executive Director

Stock Exchange Intimation for the Board Meeting of the Company to be held on February 1, 2023

Shareholding Pattern as on March 31, 2023

Shareholding Pattern as on December 31, 2022

Shareholding pattern as on September 30, 2022

Shareholding pattern as on June 2022

Corporate Governance Report as on March, 2023

Corporate Governance Report as on December 31, 2022

Corporate Governance Report as on September 30, 2022

Corporate Governance Report as on June 30, 2022

Disclosure of Related Party Transactions for the half year ended March 31, 2023 pursuant to SEBI Regulations

Disclosure of Related Party Transactions for the half year ended September 30, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2022

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2022

Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the second quarter and half year ended September 30, 2022

Outcome of the Board Meeting dated October 27, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022

Press Release on Financial Results for the second quarter and half year ended September 30, 2022

Analyst/Investors Presentation dated October 27, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022

Stock Exchange Intimation for the Board Meeting of the Company to be held on October 27, 2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exhange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2022

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the First Quarter ended June 30, 2022

Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the quarter ended June 30, 2022

Outcome of the Board Meeting dated August 9, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022

Press Release on Financial Results for the first quarter ended June 30, 2022

Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022

Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022

Stock Exchange Intimation for the Board Meeting of the Company to be held on August 9, 2022

Reaffirmation of Credit Rating by CARE Ratings

Outcome of the 83rd Annual General Meeting

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation for Business Responsibility & Sustainability Report

Intimation for Notice and Explanatory Statement of the 83rd Annual General Meeting

Intimation for Integrated Annual Report for FY 2021-22

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Reaffirmation of Credit Rating by CRISIL Ratings

Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 83rd Annual General Meeting'

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 - Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation of Communication to Shareholders - Tax Deduction on Dividend

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Annual Disclosure for Fund raising by issuance of Debt Securities by Large Entities

Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations

Company's reply to the clarification sought by the exchange

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Corrigendum to the Note 5 of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended March 31, 2022

Press Release on Financial Results for the fourth quarter and year ended March 31, 2022

Outcome of the Board Meeting dated April 29, 2022: Recommendation of Dividend for FY 2021-22

Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Initial Disclosure for Fund raising by issuance of Debt Securities by Large Entities

Outcome of the Board Meeting dated April 29, 2022: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022

Re-appointment of Statutory Auditor of the Company

Analysts/Investors Presentation dated April 29, 2022 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022

Change in name of Company’s Registrar and Transfer Agent (RTA)

Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Affirmation of Credit Rating by Fitch Ratings

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2021

Outcome of the Board Meeting dated February 10, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021

Analysts/Investors Presentation dated February 10, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021

Press Release on Financial Results for the third quarter and nine-months ended December 31, 2021

Stock Exchange Intimation of the Board Meeting of the Company to be held on February 10, 2022

Shareholding pattern as on March 2022

Shareholding pattern as on December 2021

Shareholding pattern as on September 2021

Shareholding pattern as on June 2021

Quarterly compliance report Q4 FY 22

Quarterly compliance report Q3 FY 22

Quarterly compliance report Q2 FY 22

Quarterly compliance report Q1 FY 22

Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations as per New Format

Disclosure of Related Party Transactions for the half year ended September 30, 2022 pursuant to SEBI Listing Regulations

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure of Related Party Transactions for the half year ended September 30, 2021 pursuant to Regulation 23(9) of the SEBI Listing Regulations

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended September 30, 2021

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the second quarter and half year ended September 30, 2021

Outcome of the Board Meeting dated October 27, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021

Press Release on Financial Results for the second quarter and half-year ended September 30, 2021

Analysts/Investors Presentation dated October 27, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021

Stock Exchange Intimation of the Board Meeting of the Company to be held on October 27, 2021

Reduction in rated amount and reaffirmation of credit rating by CARE Ratings

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021

Outcome of the Board Meeting dated August 5, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021

Press Release on Financial Results for the first quarter ended June 30, 2021

Analysts/Investors Presentation dated August 05, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021

Stock Exchange intimation providing details of Analysts’ Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2021

Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2021

Outcome of the 82nd Annual General Meeting

Reaffirmation of Credit Rating by CARE Ratings

Stock Exchange Intimation for corrigendum to the Integrated Annual Report FY 2020-21

Intimation under Regulation 30 Newspaper Advertisement for Transfer of Shares to IEPF on June 12, 2021

Intimation under Regulation 30 - Newspaper Advertisement 'Notice of the 82nd Annual General Meeting, E-Voting and Book Closure'

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 82nd Annual General Meeting

Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2020-21

Reaffirmation of Credit Rating by CRISIL Ratings upon reduction in quantum of rated amount of Commercial Paper

Affirmation of Credit Rating by Moody’s Investors Service

Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 82nd Annual General Meeting'

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Communication to Shareholders - Intimation on Tax Deduction on Dividend

Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021

Outcome of the Board Meeting dated May 3, 2021: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2021 and recommendation of Dividend

Outcome of Board Meeting dated May 3, 2021: Recommendation of Dividend for FY 2020-21

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations

Press Release dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021

Analysts/Investor Presentation dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for FY 2020-21

Stock Exchange Intimation of the Board Meeting of the Company to be held on May 3, 2021

Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2021 - English and Marathi

Intimation in terms of SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 pertaining to transfer of securities in physical mode

Disclosure under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement - Intimating change of the registered office of Registrar and Transfer Agent of the Company - TSR Darashaw Consultants Private Limited

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Change in Key Managerial Personnel (Chief Financial Officer) of the Company

Shifting of registered office of Registrar and Transfer Agent of the Company

Advertisement – Transfer of equity shares pursuant SEBI Circular dated November 6, 2018 - February 23, 2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Newspaper Publication of Financial Results for the third quarter and nine months ended December 31, 2020

Press Release on Financial Results for the third quarter and nine months ended December 31, 2020

Analysts/Investors Presentation dated January 28, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020

Outcome of the Board Meeting dated January 28, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020

Newspaper publication of notice of the meeting of Board of Directors to be held on January 28, 2021 - English and Marathi

Stock Exchange Intimation for the Board Meeting of the Company to be held on January 28, 2021

Clarification/confirmation on the news item appearing in Economic Times captioned ‘Tata Chemicals in advanced talks to buy debt-laden Archean unit’

Stock exchange intimation for withdrawal of Tata Chemicals (Soda Ash) Partners from the American Natural Soda Ash Corporation (ANSAC)

Shareholding pattern as on March 2021

Shareholding pattern as on December 2020

Shareholding pattern as on September 2020

Shareholding pattern as on June 2020

Quarterly compliance report Q4 FY 21

Quarterly compliance report Q3 FY 21

Quarterly compliance report Q2 FY 21

Quarterly compliance report Q1 FY 21

Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure dated December 7, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Disclosures dated December 1 and December 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock exchange intimation for appointment of Mr. N. Chandrasekaran as an additional Director and Chairman of the Company

Stock exchange intimation for resignation of Mr. Bhaskar Bhat as a Director of the Company

Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter and half year ended September 30, 2020

Outcome of the Board Meeting dated October 29, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020

Press Release on Financial Results for the quarter and half year ended September 30, 2020

Analysts/Investors Presentation dated October 29, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020

Newspaper publication of notice of the meeting of Board of Directors to be held on October 29, 2020 - English and Marathi

Stock Exchange Intimation for the Board Meeting of the Company to be held on October 29, 2020

Shifting of Investor Service Centers of Registrar and Transfer Agent of the Company

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020

Disclosure dated September 25, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation for appointment of Mr. Rajiv Dube as an Independent Director

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter ended June 30, 2020

Outcome of the Board Meeting dated July 31, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020.

Analysts/Investors Presentation dated July 31, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020

Press Release on Financial Results for the first quarter ended June 30, 2020

Newspaper publication of notice of the meeting of Board of Directors to be held on July 31, 2020 - English and Marathi

Stock Exchange Intimation of the Board Meeting of the Company to be held on July 31, 2020

Outcome of the 81st Annual General Meeting

Disclosure regarding impact of Covid-19 pandemic on the Company’s operations - Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020

Confirmation by Tata Chemicals on non-applicability of SEBI Circular dated November 26, 2018 w.r.t. Large Corporates

Annual Disclosure by Tata Chemicals Limited being identified as a Large Corporate as on March 31, 2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement for transfer of shares to IEPF Account

Newspaper Advertisement- Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Submission of Annual Secretarial Compliance Report for the Financial Year 2019-20

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 81st Annual General Meeting

Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2019-20

Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure regarding impact of Covid-19 pandemic on the Company’s operations

Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Corrigendum to the Audited Consolidated Financial Results for the year ended March 31, 2020

Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders

Communication to Shareholders - Intimation on Tax Deduction on Dividend

Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Book Closure Date pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - 81st Annual General Meeting of the Company

Date of 81st Annual General Meeting of the Company

Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Cost of Acquisition of shares of Tata Chemicals Limited and Tata Consumer Products Limited (erstwhile Tata Global Beverage Limited) as per the provisions of Sections 49(2C) and 49(2D) of the Income Tax Act, 1961

Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020

Outcome of the Board Meeting dated May 15, 2020: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2020 and recommendation of Dividend

Rescheduling of Analysts' Call and Presentation to be made at the rescheduled call

Stock Exchange Intimation of the Board Meeting of the Company to be held on May 15, 2020

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Resuming of manufacturing operations at the Company’s plants

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Shutdown/ scale down of manufacturing operations at the Company’s plants due to outbreak of Coronavirus (COVID-19)

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Clarification on the disclosures submitted under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 28, 2020 and March 5, 2020

Disclosure dated March 17, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Purchase of shares by Mr. N. Chandrasekaran

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure dated March 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Disclosure dated February 27, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Disclosures dated February 18 and 19, 2020 received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015: Inter-se transfers

Intimation of Newspaper advertisement for notice of Record Date

Intimation of the Record Date pursuant to Regulation 42 of SEBI LODR Regulations

Disclosure dated February 10, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation for Effective Date of the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited

Stock exchange intimation of Newspaper Publication for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019

Outcome of the Board Meeting dated February 3, 2020: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the third quarter and nine months ended December 31, 2019

Press Release dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for third quarter and nine months ended December 31, 2019

Analysts/Investor Presentation dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019

Rescheduling of Analyst' call on the financial results for the third quarter and nine months ended December 31, 2019

Newspaper publication of notice of the meeting of Board of Directors to be held on February 3, 2020 - English and Marathi

Stock Exchange Intimation of the Board Meeting of the Company to be held on February 3, 2020

Intimation of sanction of Scheme of Arrangement by NCLT Mumbai and Kolkata Bench

Disclosure received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Shareholding pattern as on March 2020

Shareholding pattern as on December 2019

Shareholding pattern as on September 2019

Shareholding pattern as on June 2019

Quarterly compliance report Q4 FY 20

Quarterly compliance report Q3 FY 20

Quarterly compliance report Q2 FY 20

Quarterly compliance report Q1 FY 20

Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Disclosure of Related Party Transactions for the half year ended September 30, 2019 pursuant to Regulation-23-(9)-of-the-SEBI-(Listing-Obligations-and-Disclosure-Requirements)-Regulations-2015-('Listing-Regulations')

Intimation under Regulation 30 read with Schedule III of SEBI LODR - Acquisition of remaining 25% interest in Tata Chemicals (Soda Ash) Partners Holding

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Outcome of the National Company Law Tribunal Convened Meeting of Tata Chemicals Limited held on Wednesday, October 30, 2019

Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - English

Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - Marathi

Outcome of the Board Meeting dated October 30, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the second quarter and half year ended September 30, 2019

Newspaper publication of Notice of the Meeting of the Board of Directors to be held on October 30, 2019 - English

Newspaper publication of notice of the Meeting of the Board of Directors to be held on October 30, 2019 - Marathi

Stock Exchange Intimation of the Board Meeting of the Company to be held on October 30, 2019

Appointment of Mr. K.B.S. Anand as an Independent Director of the Company

Newspaper Advertisement of Notice of the Meeting of the Equity Shareholders of Tata Chemicals Limited to be convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench

Notice of the Meeting of Equity Shareholders of Tata Chemicals Limited convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench

Intimation of reappointment of Ms Vibha Paul Rishi as an Independent Director of the Company under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirement Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Cessation of Mr. Nasser Munjee and Dr. Y. S. P. Thorat as Independent Directors of the Company

Appointment of Dr. C V Natraj as an Independent Director of the Company

Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - Marathi

Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - English

Intimation of Appointment of Director under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015

Outcome of the Board Meeting dated August 8, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the quarter ended June 30, 2019

Press Release dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019

Analysts/Investor Presentation dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019

Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - Marathi

Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - English

Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by CARE Ratings Limited

Intimation of the Board Meeting to be held on August 8, 2019

Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by Brickwork Ratings India Private Limited

Outcome of the 80th Annual General Meeting

Intimation under Regulation 30 of the Listing Regulations for re-appointment of Ms. Vibha Paul Rishi as an Independent Director

Intimation under Regulation 57(1) of the Listing Regulations of payment of Principal along with Annual Interest to the Debentureholders of 2500 – 10% Rated Taxable Unsecured Redeemable Non-Convertible Debentures

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper publication of notice of the 80th Annual General Meeting of the Company

Annual Report for FY 2018-19 under Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Notice and Explanatory Statement of the 80th Annual General Meeting

Intimation under Regulation 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Record Date and Payment of Principal, Interest and Redemption Date

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Company’s Registrar and Share Transfer Agent update

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Related Party Transactions for the half year ended March 31, 2019

Outcome of the Board Meeting held on May 15, 2019: Intimation of Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited and their respective shareholders and creditors

Intimation of Analyst / Investor Call held to discuss the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for Notice of transfer of shares to Investor Education and Protection Fund

Newspaper Advertisement (Financial Results for quarter and year ended March 31, 2019) - Marathi

Newspaper Advertisement (Financial Results for the quarter and year ended March 31, 2019) - English

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2019

Outcome of Board Meeting dated May 3, 2019: Approval of Standalone and Consolidated Financial Results for FY 2018-19

Outcome of Board Meeting dated May 3, 2019: Recommendation of Dividend for FY 2018 -19

Analysts/Investor Presentation dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19

Press Release dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations

Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - English

Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - Marathi

Intimation of the Board Meeting to be held on May 3, 2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - English

Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - Marathi

Outcome of Board Meeting held on February 5, 2019 - Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Presentation on the Analyst Call

Press Release on the Financial Results for the quarter ended December 31, 2018

Newspaper publication of notice of meeting of Board of Directors (05.02.2019) - English & Marathi

Intimation under Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)

Shareholding pattern as on March 2019

Shareholding pattern as on December 2018

Shareholding pattern as on September 2018

Shareholding pattern as on June 2018

Quarterly compliance report Q4 FY 19

Quarterly compliance report Q3 FY 19

Disclosure of Related Partv Transactions for the half year ended March 31. 2019 pursuant to Requlation 23(9) of the SEBI (Listino Obliqations and Disclosure Requirements) Requlations. 2015 ('Listinq Requlations')

Intimation of letter sent to shareholders holding shares in physical form for updating PAN and Bank details and converting their holdings into Demat

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - Marathi

Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - English

Non-convertible Debentures - Compliance of Regulations 52(4), 52(5) and 52(7) of SEBI Listing Regulations for the half year ended September 30, 2018

lntimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Press Release on the Financial Results for the quarter ended September 30, 2018

MoU signed by the Company with CSIR – CECRI (Central Electrochemical Research Institute), Karaikudi

Newspaper publication of notice of meeting of Board of Directors (02.11.2018) - English & Marathi

Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - English

Presentation on the Analyst Call

lntimation under Regulations 30 and 33 of SEBI (Listinq Obligations and Disclosure Requirements) Regulations. 2015

Press Release on the Financial Results for the quarter ended June 30, 2018

Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - Marathi

Notice of Board Meeting - August 13, 2018

Newspaper publication of notice of meeting of Board of Directors - Marathi

Newspaper publication of notice of meeting of Board of Directors - English

Intimation of change in Segment Reporting of Tata Chemicals Limited under Regulation 30 of the SEBI Listing Regulations

Outcome of the 79th Annual General Meeting

Webcast of 79th Annual General Meeting

Intimation under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for notice of 79th AGM and Book Closure dates

Intimation under Reg. 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Payment of Annual Interest to Debentureholders

Notice of 79th Annual General Meeting

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Completion of acquisition of precipitated silica business of Allied Silica Limited

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI Listing Regulations for sale and disposal of Phosphatic Fertilisers business and the Trading business to IRC Agrochemicals Private Limited effective June 1, 2018

Intimation under Regulation 30 of SEBI Listing Regulations for transfer of Ordinary Shares of the Company to Investor Education and Protection Fund

Intimation under Regulation 50(1) and 60(2) of SEBI Listing Regulations of Record Date and Payment of Interest Date

Outcome of Board Meeting dated May 18, 2018 approving the Standalone and Consolidated Financial Results for FY 2017-18 and declaration of Dividend.

Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018) - Marathi

Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018 - English

Press Release dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18

Intimation under Regulation 30 of SEBI Listing Regulations regarding re-appointment of Mr. R. Mukundan as Managing Director and CEO.

Undertaking for the year ended March 31, 2018 pursuant to Regulation 57 of SEBI Listing Regulations

Details of Non-convertible Debentures for the year ended March 31, 2018 pursuant to Regulation 52(4) and 52(5) of SEBI Listing Regulations

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (NSE)

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (BSE)

Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18

Analysts' Call on Audited Financial Results for the year ended 31st March 2018

Notice for potponement of Board Meeting- English

Notice for postponement of Board Meeting- Marathi

Postponement of Board Meeting to be held on May 7, 2018

Rescheduled Bord Meeting 6th May, 2018

Notice of Board Meeting - 7th May, 2018

Regulation 30 as 'BTA with ASL'

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation - Corrigendum to intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

lntimation under Reoulation 30 of the SEBI (Listinq Obliqations and Disclosure Requirements) Requlations. 2015

Stock Exchange Intimation under Regulation 30 - Appointment of Directors

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Analysts Presentation for Q3 Results dated 06.02.2018 of FY 2017-18

Press Release for Q3 Results dated 06.02.2018 of FY 2017-18

Outcome of Board Meeting dated 06.02.2018 for Q3 Results of FY 2017-18

Notice of Board Meeting - 6th February, 2018

Completion of Sale and Transfer of Urea and Customized Fertilisers Business to Yara Fertilisers India Private Limited (“Yara”)

Shareholding pattern as on March 2018

Shareholding pattern as on December 2017

Shareholding pattern as on September 2017

Shareholding pattern as on June 2017

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot 2017

Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot Notice

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sanction of Scheme of Arrangement for the transfer of the business of Urea and customized fertilisers located at Babrala, Uttar Pradesh to Yara Fertilisers India Private Limited by NCLT, Mumbai Bench, Mumbai

Intimation of incorporation of new wholly owned subsidiary under Section 8 of the Companies Act, 2013

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - English

Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - Marathi

Press Release for Q2 Results dated 13.11.2017 of FY 2017-18

Analysts Presentation for Q2 Results dated 13.11.2017 of FY 2017-18

Outcome of Board Meeting dated 13.11.2017 for Q2 Results of FY 2017-18

Certificate under Regulation 52(4) & 52(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2017.

Intimation for Sale of Phosphatic Business

Press Release for Sale of Phosphatic Fertilisers Business

Newspaper publication of notice of meeting of board of directors - Navshakti

Newspaper publication of notice of meeting of board of directors - Business Standard

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

Analysts call on 26th September, 2017

Sale of equity shares of Tata Global Beverages Limited

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

Proposed Sale of equity shares of Tata Global Beverages Limited

Analysts call - 20th September, 2017

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015

Analysts call - 12th September, 2017

Annual Report 2016-17 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Outcome of Board Meeting for Q1 Results of FY 2017-18

Press Release for Q1 Results of FY 2017-18

Analysts Presentation for Q1 Results of FY 2017-18

Regulation 30 of the SEBI, LODR 2015 - Unnati Inorganics Private Limited - Cancellation of Transaction

Regulation 29 (1) (a) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - regulations of the Board Meeting - 08 August 2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

Certilication under Regulation 57(l) of the SEBI (LODR) Regulations' 2015

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

Outcome of board meeting in accordance with the SEBI (Listing obligations and disclosure requirements) regulations, 2015

Submission of presentation made to Analysts / Investors

Undertaking for the year ended 31st March, 2017 under Regulation 57 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015

Details of Non-Convertible Debentures for the year ended March 31, 2017

Audited results for the Press Release for the year ended March 31, 2017

TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE

Board Meeting

SE letter BTA Unnati Inorganics - Intimation under regulation 30 of the SEBI

Newspaper Advertisement of Equity Shareholders Meeting

Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015

IEPF Advertisement - for Transfer of Shares to Investor Education and Protection Fund (IEPF) Account

Institutional Investor Meetings under the SEBI Requlations, 2015

Institutional Investor Meetinqs under the SEBI (LODR) Requlations, 2015

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015

Institutional Investor Meetings under the SEBI Requlations, 2015

lnstitutional lnvestor Meetings uncler the SEBI Requlations, 2015

SE Analyst Meet - Intimation of schedule of analyst

SE Letter Haldia - Intimation under regulation 30 of the SEBI

Regulation 30 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - Outcome of the Board Meeting - 08 February 2017

Outcome of the Board Meeting - 08 February 2017

Presentation for Analysts' call - 08 February 2017

Press Release on Financial Results for the Q3 and nine months ended December 31, 2016

Memorandum of understanding (MOU) with Government of Andhra Pradesh

Board meeting notice for quarterly results - 08 February 2017

Credit Rating - Non-Convertible Debenture (NCD) of Rs. 250 crores

Shareholding pattern as on March 2017

Shareholding pattern as on December 2016

Shareholding pattern as on September 2016

Shareholding pattern as on June 2016

Credit ratings

Change in board of directors

Proceedings and voting results of the extra general meeting - 23 December 2016

Resignation of Mr Cyrus P Mistry as Director

Notice of motion number 3504

Representation of Mr Nusli N Wadia - Stock exchange letter

Notice of motion

Representation of Mr Cyrus P Mistry - Stock exchange letter

Analysts call announcement December 5, 2016

Notice of extraordinary general meeting - December 23, 2016

Analysts call announcement November 21-22, 2016

Outcome of the Board Meeting November 22, 2016

Analysts call announcement November 25, 2016

Analysts call announcement November 16, 2016

Resignation of Mr Bhaskar Bhat, non-executive, non independent director

Disclosure under Regulation 30 of the SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

Resignation of Dr Nirmalya Kumar, non-executive director

NSE Email and Letter dated October 27, 2016 on News Clarification

Analysts call announcement November 11, 2016

Review of credit rating - NCD of Rs250 crore

Replacement of Mr Cyrus P Mistry as Chairman of Tata Sons Limited with Mr Ratan N. Tata as interim Chairman of Tata Sons Limited

MoU with Sanjana cryogenics - 12 September 2016

Eknath Kshirsagar retirement

Investor call intimation - 12 September 2016

Crisil rating

Investor meeting - 31 August 2016

Intimation of schedule of analyst/ institutional investor meetings - 23 August 2016

Board meeting notice for quarterly results 05 August 2016

Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations

Intimation of schedule of analyst/ institutional investor meetings

Intimation to the exchange pursuant to regulation 57(2) of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015

Details of nonconvertible debentures for the half vear ended March 31, 2016

Outcome of board meeting in accordance with the SEBI (Listing obliqations and disclosure requirements) regulations, 2015

Metahelix has entered into a joint venture with Mr Suresh Gobindram Vaswani

Appointment of Dr Nirmalya Kumar as an additional director

Details of non-convertible debentures for the half year ended March 31, 2016

Regulation 29 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 (LODR) regulations

lntimation of schedule of analyst / lnstitutional lnvestor meetinqs under the SEBI (Listino obliqations and disclosure requirements) requlations. 2015

Notice for board meeting - Q4 results

Babrala plant operations resumed

MoU with Sanjana Cryogenics Storage Ltd

Schedule of analyst / institutional investor meeting

Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations - 30 March 2016

Temporary shutdown of Babrala plant

Quarterly CG reports

Intimation under regulation 30 of the SEBI

Intimation under regulation 30 of the SEBI (Listing obligations and disclosure requirements) regulations, 2015

Regulation 30 (5) of the listing regulations

Shareholding pattern as on March 2016

Shareholding pattern as on December 2015

Shareholding pattern as on September 2015

Shareholding pattern as on June 2015

Quarterly compliance report Q2 FY 16

Quarterly compliance report Q1 FY 16

Retirement of Mr. R. Gopalakrishnan as non-executive director and vice chairman of the company

Resignation of Prasad R. Menon as non-executive, non-independent director

Appointment of Bhaskar Bhat as an additional director

Appointment of John Mulhall as the chief financial officer and key managerial personnel of the company

Retirement of PK Ghose, executive director and CFO

Resignation of Dr Vijay L Kelkar, non-executive independent director

Shareholding pattern as on March 2015

Shareholding pattern as on December 2014

Shareholding pattern as on September 2014

Shareholding pattern as on June 2014

Quarterly compliance report Q4 FY 15

Quarterly compliance report Q3 FY 15

Quarterly compliance report Q2 FY 15

Quarterly compliance report Q1 FY 15

Shareholding pattern as on March 2014

Shareholding pattern as on December 2013

Shareholding pattern as on September 2013

Shareholding pattern as on June 2013

Shareholding pattern as on March 2013

Shareholding pattern as on December 2012

Shareholding pattern as on September 2012

Shareholding pattern as on June 2012

Shareholding pattern as on March 2012

Shareholding pattern as on December 2011

Shareholding pattern as on September 2011

Shareholding pattern as on June 2011

Shareholding pattern as on March 2011

Shareholding pattern as on December 2010

Shareholding pattern as on September 2010

Shareholding pattern as on March 2010

Shareholding pattern as on December 2009

Shareholding pattern as on September 2009

Shareholding pattern as on June 2009

Shareholding pattern as on March 2009

Shareholding pattern as on December 2008

Shareholding pattern as on September 2008

Shareholding pattern as on June 2008

Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18